Armata Pharmaceuticals, Inc.
ARMP · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Birx Deborah: Form 4
Insider disclosure · Filed · Report period 10 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ARMP · 04216R102 - Common Stock, $0.01 par value
Company details and SEC sources
CIK 0000921114 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ARMP on NYSE
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 5005 Mcconnell Ave, Los Angeles, CA, 90066
- Incorporated in
- WA
- Fiscal year end
- 31 December
- Former names on EDGAR
- AmpliPhi Biosciences Corp (to 08 May 2019), TARGETED GENETICS CORP /WA/ (to 11 Feb 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields